Verastem Advances with Phase 3 Trial Progress and Product Launch Boosting Prospects
Verastem, Inc. (NASDAQ:VSTM), operating from its headquarters in Massachusetts, is a development-stage biopharmaceutical company.
Verastem Inc. (VSTM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 4,205,968 | $17,454,767 | -13% | 0.03% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,404,425 | $14,128,364 | +63% | 0.5% |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,954,735 | $12,262,150 | +29% | 0.48% |
| 4. | Armistice Capital Steven Boyd | 2,136,000 | $8,864,400 | 0.15% | |
| 5. | AIGH Investment Partners Orin Hirschman | 2,003,179 | $8,313,193 | -15% | 3.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.84 | 2,000 | $7,680.00 | 2,000 | 2017-09-05 | Filing | |
| $2.17 | 50,000 | $108,500.00 | 218,000 | 2020-12-04 | Filing | |
| $3.21 | 33,000 | $105,930.00 | 168,000 | 2019-03-15 | Filing | |
| $7.31 | 5,000 | $36,550.00 | 135,000 | 2018-09-28 | Filing | |
| $7.30 | 3,000 | $21,900.00 | 10,700 | 2018-09-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.81 | 1,332 | $7,738.92 | 442,507 | 2025-08-06 | Filing | |
| $5.13 | 17,808 | $91,355.04 | 443,839 | 2025-06-20 | Filing | |
| $4.71 | 25 | $117.75 | 109,920 | 2025-06-23 | Filing | |
| $5.13 | 4,110 | $21,084.30 | 109,945 | 2025-06-20 | Filing | |
| $5.65 | 335 | $1,892.75 | 461,647 | 2025-06-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,251,616 | $17,644,206 | 0.25% | |
| 2. | 3,423,617 | $14,208,010 | 0% | |
| 3. | 2,758,914 | $11,449,494 | 0% | |
| 4. | 2,454,519 | $10,186,254 | 0.24% | |
| 5. | 2,251,424 | $9,343,410 | 0% |
News See All
11 Best Short Squeeze Stocks to Buy Now
The latest U.S. tariff wave has created a suitable environment where short squeeze investments will thrive.
Verastem, Inc. (NASDAQ:VSTM) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Rebecca, and I will be your conference operator today.
5 Best Medical Stocks Under $5
Geron Corporation (NASDAQ:GERN) is a biopharmaceutical company that is involved in the development of drugs for advanced blood cancers.
10 Long-Term Stocks to Buy During Recessions
In this article, we discuss the 10 long-term stocks to buy during recessions.
Hedge Fund and Insider Trading News: Catherine Wood, Dan Loeb, Ray Dalio, Millennium Management, Chessica LP, Incyte Corporation (INCY), Verastem, Inc. (VSTM), and More
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "bubble-type" tech stocks...
10 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
10 Best Biotech Stocks Under $5
The biotech industry has seen strong growth in terms of funding through venture capitalists, joint ventures, and co-developments in the recent past.
11 Best Long-Term Stocks To Buy Now
Soaring valuations and the influx of retail investors has altered overall market dynamics in favor of growth stocks in recent years.